Member Info for Paul2566

Thats a good question, I really don't know.
MXC has been listed a lot longer on ASX and the investor sentiment may be different.
I think particularly with a stock like this at this stage of its development, sentiment has more effect on the SP to some degree.
As the value increases I believe the fundamentals will play a bigger part in the SP, but sentiment will always be one of the driving forces.

OZ beat me to it.

I don't think of it as 2 markets as you are correct we would be continually following the other up or down.
I think of it as an early and late shift, with different factors continually influencing the SP, and the 2 shifts not alays getting the news at the same time.
The AUX market simply tells me there is no negative news yet,and the market in general remains positive about MXC.

If the ASX market is anything to go by, there could be an 8% upside today.
Its nearly market close and its currently 8.33% up at 0.065AUD.

Wolf
LOL really..................... How now brown cow.
What is your point.

Ah you are a better human than I.
I am only here for the money, although I do draw the line at tobacco stocks.

Golf I hope you are right and I can see that could be possible.

I do like being wrong when it makes me money.

5p would be over 150% increase in around 7 months.
8p is 250%, which would be nice, but we will have to see.

Good news indeed, raising the company profile is always good.
If the trial goes well, and I have no reason to think otherwise, it could open more doors.
At the current SP I think it will make me money, the only question is how much.
I bought this stock as a high risk investment, because I could see its potential.
My view is that it remains high risk, but much less so than when I initially bought.
I'm bullish on this stock, and expect to see some reasonable gains in SP, (backed by an increase in value), by April 2022.
If all the news bears fruit I wouldn't be overly surprised to see an SP of 5p or very near by that time.

Andym
Spot on.

Philm
I agree.
The idea that posts on a bb, can have any effect on the SP of a stock 100's millions of shares in issue is absolutly ridiculous.
You may as well try and tell me that by spitting in the ocean I will see the tide rise.
I suspect there are a lot of naieve, desperate, and novice investors on these bb's, which is why anyone who makes any financial decisions based on what they read here is crazey.
I find it useful to make me consider things I might otherwise no have thought of, and examine different points of view.
It's just a shame that people seem to take it personally, and some of the posts are less than useful for anything.
MXC is just one of 21 stocks I hold, and I have no attachment to it whatsoever, its just a vehicle to make money.

Exactly what Magstar said.
ASX isn't exactly going ape over the news.
If the data from what is in effect a trial of 10 patients goes well, then it should add a little more value to the stock.

Have you actually read what the RNS says, I suggest you read it again.

Wolf76
Reality and deramping are two different things.
Suggesting its going to be 15p in the short term is something else entirely.
Boom.

There shouldn't be any reason for seasoned investors to lose confidence, nothing has changed.
Its just that the SP is more realistic based on what is happening now, not too inflated by what might happen.
The end of the month may see the US deal manifest into something more tangible.
The changes in dividend tax in the UK in April 22 haven't helped the market in general.
In addition the announcement by the European Central Bank to slow down pandemic related bond purchases has caused concern among some.
I appreciate the US deal will only mean $750,000 (£540,000) initially but it makes the rest of the deal more likely.
That could cause a rise in SP, maybe nearer to 3.2p next month, although in reality the value would still be lagging a bit, which is often the way with growth stocks.
If India becomes a true market for MXC I can see the SP pushing over 3.5p.

Am I missing something, this is from 2020.

hasiba
To each their own, but personally I buy stocks at fair value and hold for medium to long term, some I have held for 20 years.
I tend towards dividend stocks, with a few that provide both and the odd growth stock.
MXC is for me a very unusual stock to buy, but it caught my imagination. It is however only one of the 21 stocks I hold with about 5% - 6% held in each stock.
Over the years I have held that all stocks have an inherent value, which can then be raised or lowered by additional factors.
My experience is that where a stock has risen on sentiment, potential, and hype, when stocks fail to meet expectations they fall back towards fair value. In the case of growth stocks it tends to be a little more dramatic.
What I can say with absolute confidence is that the growth we have seen in the last couple of days cannot continue, it simply isn't possible. The mcap is way over what it should be for a company at this stage of its development.
I think MGC Pharma could be a real winner, but there are many on this BB who are inexperienced and have unrealistic expectations.
Don't forget MXC will still need to raise further funds in well under 12 months, and I don't believe they will have any problem doing so, but they remain (at the moment) a company that far exceeds income with expense.
This all sounds very negative as I read it, but I repeat I am bullish on this stock, and I understand the huge costs of developing pharma products and getting them to the end user, and is to be expected.

That may be a good move, as I think it could continue to rise a bit more, but if it gets to 4p without the current news bearing fruit, or further good news, personally I'll take a long hard look at my options.
Whether I close my position, or not I will definately buy back in as I believe in the company, the only question is will it cost me more or less, and no one knows for sure.

Enrico
Its not a cure I'm afraid, it treats the symptoms and reduces the severity of the condition.
£1 not in the next year, and probably well beyond. I believe it will get there in a realistic timeframe.
This stock is currently worth around 2.6p, and its trading at a premium, which is to be expected given the news, but too great a disparity will not continue.
If you are happy to hold through the drops it shouldn't make any real difference over the medium to long term (5-10 years).
A lot of less experienced investors here will however likly become disheartened, along with the associated posts.
I'm quite happy with the 11.22% paper profit I have in this stock, but if it goes too high too fast, I will review the situation.

Yes thats all very pleasant but cannot be sustained.
MGC Pharma is a growth stock.
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth often look expensive, and usually trading at a high P/E ratio or in this case none is available.
However while I accept such valuations could be relatively cheap if the company continues to grow, which will drive the share price up.
However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
I am bullish on MXC, but based on value its getting expensive.
If a stocks value and its SP diverge too much, it usually corrects itself one way or another.
I can see a lot of potential in this stock, and I don't want a sudden drop to damage investor sentiment.
Slower and long term is better than boom and bust, unless unlike me you are a wizard at timing the market.